Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.
The International Bladder Cancer Group built on the existing framework provided by current guidelines, and provided consensus on the definitions of low, intermediate and high risk nonmuscle invasive bladder cancer, as well as practical recommendations for the treatment of patients in each of these risk categories. Expand
A case‐control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet
The age‐adjusted incidence of prostate cancer is low in Japan, and it has been suggested that the traditional Japanese diet, which includes many soy products, plays a preventive role against prostate… Expand
Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.
- D. White, P. Camus, +9 authors R. Motzer
- American journal of respiratory and critical care…
- 1 August 2010
Early recognition, prompt intervention, and a conservative approach are important in managing the risk associated with noninfectious pneumonitis in association with everolimus. Expand
Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
- M. Cooperberg, S. Hinotsu, +4 authors H. Akaza
- Journal of clinical oncology : official journal…
- 10 September 2009
The novel J-CAPRA is the first risk instrument developed and validated for patients undergoing PADT, applicable to those with both localized and advanced disease, and performs well in diverse populations. Expand
Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis
- Katsuyuki Iida, K. Itoh, +6 authors Masayuki Yamamoto
- Chemistry, Medicine
- Cancer Research
- 15 September 2004
Results show that Nrf2 and its downstream target genes are responsible for BBN detoxification and oltipraz prevents carcinogenesis by BBN by enhancing detoxification of this carcinogen in the liver and urinary bladder. Expand
Incidence of venous thromboembolism following major abdominal surgery: a multi‐center, prospective epidemiological study in Japan
- M. Sakon, Y. Maehara, H. Yoshikawa, H. Akaza
- Journal of thrombosis and haemostasis : JTH
- 1 March 2006
Venous thromboembolism is common in Japanese patients undergoing major abdominal surgery and Pharmacologic thromboprophylaxis is considered essential, particularly in those patients with multiple, potential risk factors. Expand
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
The expression of E-cadherin-associated cytoplasmic molecules (alpha-, beta-, and gamma-catenins and p120cas) was evaluated to clarify whether or not the pattern of their expression could provide additional prognostic information beyond that from E- cadher in alone. Expand
Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.
- H. Akaza, N. Miyanaga, +8 authors A. Pantuck
- Japanese journal of clinical oncology
- 1 February 2004
The results suggest that the ability of producing equol or equol itself is closely related to the lower incidence of prostate cancer and that a diet based on soybean isoflavones will be useful in preventing prostate cancer. Expand
Antineoplastic activity of honey in an experimental bladder cancer implantation model: In vivo and in vitro studies
- T. Swellam, N. Miyanaga, +4 authors H. Akaza
- International journal of urology : official…
- 1 April 2003
The antitumor effect of bee honey against bladder cancer was examined in vitro and in vivo and the effects were assessed by the tumor growth. Expand
Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy-Associated Adverse Events.
Cystitis and hematuria are side effects common to both chemotherapy and BCG, and educating health care professionals about proper catheterisation techniques and instilling BCG at least 2 wk following a TURBT may be a reasonable option. Expand